PREVAIL III: Clinical, Immunologic, and Virologic Follow‐up of Survivors of Ebola Virus Disease is a study of Ebola virus disease (EVD) to assess whether survivors of EVD can transmit infection to household and sexual contacts. A cohort of EVD survivors and close contacts are being followed for five years.